InvestorsHub Logo
Followers 99
Posts 2761
Boards Moderated 2
Alias Born 02/10/2004

Re: latin blood post# 729

Monday, 04/14/2008 4:15:48 PM

Monday, April 14, 2008 4:15:48 PM

Post# of 738
CRM: latinblood, it looks like today's CRM/GOOG news didn't cause much frenzied enthusiasm....and the sellers outnumbered the buyer of this news.

There just doesn't seam to be much benefit in this deal for CRM IMO. The AP news said Google Aps sold less than $200M last year.

Then, as you said, others are following suit. I expect that the premium the market has been willing to give CRM as the innovator might come crashing down as the competition mounts it's campaign to innovate. ORCL is inovating, SAP is innovating, and MSFT is pricing their SaaS CRM at a 50% discount to CRMs. I would expect to see growth continue to slow...and margins to erode....and that's why I'm short by owning the Jan '09 $55 Puts.

The double top in the chart looks to be shaping up nicely to.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.